C-Rad AB (CRAD B):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:C-Rad AB (CRAD B) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7500
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
C-Rad AB (C-Rad) is a medical device company that develops, manufactures and markets advanced radiation therapy equipments. The company offers products and solutions for patient positioning, tumor localization, and radiation treatment systems. Its products include sentinel 4DCT, catalyst HD, catalyst Tomo, catalyst PT, Cypra laser, and Gemini products. C-Rad’s senitel products provide a surface contour laser scanning system for patient positioning, monitoring and gating applications. The company’s Gemini product is a detector system used for tumor localization. It provides installation, application training, and aftersales services. The markets its products through a network of distributors in Sweden, Korea, India, Thailand, China, Taiwan, Poland, Belgium, the Netherlands, Spain, France, the UK, and others. C-Rad is headquartered in Uppsala, Sweden.

C-Rad AB (CRAD B) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
C-Rad AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
C-Rad AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6
C-Rad AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
C-Rad AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
C-Rad AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
C-Rad AB, Medical Equipment, Deal Details 10
Partnerships 10
GE Healthcare Enters into Distribution Agreement with C-Rad 10
Equity Offering 11
C-Rad Raises USD2.5 Million in Private Placement of Series B Shares 11
C-RAD Raises USD5.4 Million in Rights Offering of Shares 12
C-RAD to Raise USD3 Million in Rights Offering of Series B Shares 14
Acquisition 15
C-Rad Acquires Remaining 71% Stake in Cyrpa International 15
C-Rad Acquired 29% Stake In Cyrpa International, Radiotherapy Products Developer, For USD1.4 Million 17
C-Rad AB – Key Competitors 18
C-Rad AB – Key Employees 19
C-Rad AB – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 17, 2018: C-RAD – Interim report January-June 2018 21
Apr 26, 2018: C-RAD: Interim report January-March 2018 22
Jan 31, 2018: C-RAD AB – Consolidated Year-End report January-December 2017 23
Oct 27, 2017: C-RAD – Interim report January-September 2017 24
Corporate Communications 25
Aug 14, 2018: C-RAD has appointed Cecilia Danckwardt-Lilliestrom as new CFO 25
Legal and Regulatory 26
Jun 20, 2017: Appeal Court final resolution of dispute over C-RAD’s entitlement to patents 26
Other Significant Developments 27
Dec 13, 2017: Update on C-RAD delivery of its advanced surface tracking solution to Swedish Cancer Center Nya Karolinska Solna 27
Jan 30, 2017: C-RAD and MD Anderson Cancer Center concluded agreement to supply innovative SIGRT solution 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
C-Rad AB, Medical Equipment, Key Facts, 2017 2
C-Rad AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
C-Rad AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
C-Rad AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6
C-Rad AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
C-Rad AB, Deals By Market, 2012 to YTD 2018 8
C-Rad AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
GE Healthcare Enters into Distribution Agreement with C-Rad 10
C-Rad Raises USD2.5 Million in Private Placement of Series B Shares 11
C-RAD Raises USD5.4 Million in Rights Offering of Shares 12
C-RAD to Raise USD3 Million in Rights Offering of Series B Shares 14
C-Rad Acquires Remaining 71% Stake in Cyrpa International 15
C-Rad Acquired 29% Stake In Cyrpa International, Radiotherapy Products Developer, For USD1.4 Million 17
C-Rad AB, Key Competitors 18
C-Rad AB, Key Employees 19
C-Rad AB, Subsidiaries 20

List of Figures
C-Rad AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
C-Rad AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
C-Rad AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
C-Rad AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
C-Rad AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
C-Rad AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
C-Rad AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
C-Rad AB, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[C-Rad AB (CRAD B):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vizrt Group AS:企業の戦略的SWOT分析
    Vizrt Group AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Carr’s Group Plc (CARR):企業の財務・戦略的SWOT分析
    Carr's Group Plc (CARR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • DecImmune Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DecImmune Therapeutics Inc (DecImmune) is a pharmaceutical research company. The company develops a humanised antibody, which is used in preventing tissue damage and block inflammation caused from vascular injuries. It conducts research and development on N2, an innate IgM-mediated auto-immu …
  • SI-Bone Inc:医療機器:M&Aディール及び事業提携情報
    Summary SI-Bone Inc (SI-BONE) is a medical device company that develops, manufactures and distributes diagnosing and treating patients with SI joint disorders products and tools. The company offers medical devices for patients with low back issues, degenerative sacroiliitis, and SI joint disruptions …
  • Cathay Pacific Airways Limited:戦略・SWOT・企業財務分析
    Cathay Pacific Airways Limited - Strategy, SWOT and Corporate Finance Report Summary Cathay Pacific Airways Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Nobel Biocare Services AG:企業の戦略的SWOT分析
    Nobel Biocare Services AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Oncor Electric Delivery Co LLC:企業の戦略的SWOT分析
    Oncor Electric Delivery Co LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Super Dragon Technology Co., Ltd. (9955):企業の財務・戦略的SWOT分析
    Super Dragon Technology Co., Ltd. (9955) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • CMS Energy Corporation:発電所・企業SWOT分析
    CMS Energy Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employ …
  • London North West Healthcare NHS Trust:企業の戦略的SWOT分析
    London North West Healthcare NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • ALK-Abello AS (ALK B):企業の財務・戦略的SWOT分析
    ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Texwinca Holdings Limited:企業の戦略・SWOT・財務情報
    Texwinca Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Texwinca Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • The Arab Contractors Osman Ahmed Osman & Co:企業の戦略・SWOT・財務情報
    The Arab Contractors Osman Ahmed Osman & Co - Strategy, SWOT and Corporate Finance Report Summary The Arab Contractors Osman Ahmed Osman & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Globeleq Africa Ltd:企業の戦略的SWOT分析
    Globeleq Africa Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Airbus SE (AIR):企業の財務・戦略的SWOT分析
    Airbus SE (AIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Kedrion SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Kedrion SpA (Kedrion) collects and fractionates blood plasma to develop, produce and distribute plasma-derived therapies. The company’s products are used for the treatment of rare and serious disorders such as hemophilia, immune deficiency and neurological disorders. It also offers products …
  • IDBI Bank Ltd:企業の戦略・SWOT・財務情報
    IDBI Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary IDBI Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Basin Electric Power Cooperative:発電所・企業SWOT分析
    Basin Electric Power Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Patrys Ltd (PAB):企業の財務・戦略的SWOT分析
    Summary Patrys Ltd (Patrys) is a therapeutic antibody development company focused on IgM antibodies and IgG antibody fragments in the field of oncology. The company's pipeline products include PAT-SC an immunoglobulin M type antibody used for the treatment of gastric cancer PAT-SM is a fully human m …
  • Whitehaven Coal Ltd:企業のM&A・事業提携・投資動向
    Whitehaven Coal Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Whitehaven Coal Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆